2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
The ESC/EAS Guidelines represent the views of the ESC and EAS, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The ESC and EAS is not responsible in the event of any…
Knowledge Hub · Research → Trading Insight
Medicine · Medical prescription · Health professionals · Health care · Ambiguity · Medical emergency · Public relations · Nursing
# 2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
> OpenAlex Metadata Hub · https://openalex.org/W3183857127
## Bibliographic
- **DOI:** 10.1093/eurheartj/ehz455
- **Year:** 2019
- **Citations:** 8957
- **Open Access:** Yes (bronze)
- **License:** —
- **Source:** https://academic.oup.com/eurheartj/article-pdf/41/1/111/33707502/ehz455.pdf
## Authors
- François Mach
- Colin Baigent
- Alberico L. Catapano
- Konstantinos C. Koskinas
- Manuela Casula
- Lina Badimón
- M. John Chapman
- Guy G De Backer
- Victoria Delgado
- Brian A. Ference
- Ian M Graham
- Alison Halliday
- Ulf Landmesser
- Borislava Mihaylova
- Terje R. Pedersen
- Gabriele Riccardi
- Dimitrios J Richter
- Marc S. Sabatine
- Marja‐Riitta Taskinen
- Lale Tokgozoglu
- Olov Wiklund
- ESC Scientific Document Group
- Christian Mueller
- Heinz Drexel
- Victor Aboyans
- Alberto Corsini
- Wolfram Doehner
- Michel Farnier
- Bruna Gigante
- Meral Kayıkçıoğlu
- Goran Krstačić
- Ekaterini Lambrinou
- Basil S. Lewis
- Josep Masip
- Philippe Moulin
- Steffen E. Petersen
- Anna Sonia Petronio
- Massimo Piepoli
- Xavier Pintó
- Lorenz Räber
- Kausik K. Ray
- Željko Reiner
- Walter F. Riesen
- Marco Roffi
- Jean-Paul Schmid
- Е. V. Shlyakhto
- Iain A Simpson
- Erik S.G. Stroes
- Isabella Sudano
- Alexandros D. Tselepis
- Margus Viigimaa
- Cécile Vindis
- Alexander Vonbank
- Michal Vrablik
- Mislav Vrsalović
- José Luis Zamorano
- Jean-Philippe Collet
- Konstantinos C. Koskinas
- Manuela Casula
- Lina Badimon
- M. John Chapman
- Guy G De Backer
- Victoria Delgado
- Brian A. Ference
- Ian M Graham
- Alison Halliday
- Ulf Landmesser
- Borislava Mihaylova
- Terje R Pedersen
- Gabriele Riccardi
- Dimitrios J Richter
- Marc S. Sabatine
- Marja‐Riitta Taskinen
- Lale Tokgozoglu
- Olov Wiklund
- Stephan Windecker
- Victor Aboyans
- Colin Baigent
- Jean-Philippe Collet
- Verónica Dean
- Victoria Delgado
- Donna Fitzsimons
- Chris P Gale
- Diederick E. Grobbee
- Sigrun Halvorsen
- Gerhard Hindricks
- Bernard Iung
- Peter Jüni
- Hugo A. Katus
- Ulf Landmesser
- Christophe Leclercq
- Maddalena Lettino
- Basil S Lewis
- Bela Merkely
- Christian Mueller
- Steffen E. Petersen
- Anna Sonia Petronio
- Dimitrios J Richter
- Marco Roffi
- Е. V. Shlyakhto
## Abstract
The ESC/EAS Guidelines represent the views of the ESC and EAS, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The ESC and EAS is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the ESC/EAS Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC/EAS Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the ESC/EAS Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC/EAS Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
## Keywords
Medicine, Medical prescription, Health professionals, Health care, Ambiguity, Medical emergency, Public relations, Nursing, Law
## Concepts
- Medicine
- Medical prescription
- Health professionals
- Health care
- Ambiguity
- Medical emergency
- Public relations
- Nursing
- Law
- Philosophy
- Political science
- Linguistics
---
*Metadata only — full text not imported unless Open Access license permits.*
Bài “2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>” được TradingBase chuyển thành Knowledge Product cho trader — không phải trang đọc abstract OpenAlex.
Tóm lược học thuật (đã diễn giải): The ESC/EAS Guidelines represent the views of the ESC and EAS, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The ESC and EAS is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the ESC/EAS Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC/EAS Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the ESC/EAS Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to mak…
Phần Trading Insights bên dưới nối nghiên cứu với Forex, vàng, USD, lãi suất và risk regime — để bạn đưa vào journal và playbook.
Metadata DOI/OA chỉ là rail tham chiếu; nội dung chính là summary, takeaways và ứng dụng thị trường do Content Factory sinh.
1. The ESC/EAS Guidelines represent the views of the ESC and EAS, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication.
2. The ESC and EAS is not responsible in the event of any contradiction, discrepancy, and/or ambiguity between the ESC/EAS Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies.
3. Health professionals are encouraged to take the ESC/EAS Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic, or therapeutic medical strategies; however, the ESC/EAS Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver.
4. Nor do the ESC/EAS Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations.
5. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
Tài liệu giúp trader hệ thống hóa khái niệm quanh “2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modificat” — ưu tiên chuyển thành checklist quan sát thị trường thay vì copy abstract.
Gắn 1–2 giả thuyết giao dịch có thể kiểm chứng trên journal (entry bias, invalidation, session) trước khi scale size.
Góc Forex: đối chiếu kết luận bài với hành giá gần nhất và lịch tin impact cao trước khi vào lệnh.
Góc Gold (XAUUSD): đối chiếu kết luận bài với hành giá gần nhất và lịch tin impact cao trước khi vào lệnh.
Trading: rút 1 bias hoặc 1 setup hypothesis từ Key Takeaways, test trên demo/journal trước khi live.
Risk: chuyển insight thành rule (max risk/trade, pause quanh tin, correlation USD–vàng) và gắn vào playbook.